Well, I looked into it and saw a dose-response curve where Llewellyn goes on to talk about the effectiveness of AAS at supraphyiological doses. In essence, he says that low doses do nothing, mid doses do the most good, and you don't get much for high doses. As a reference, I saw him regularly post low dose cycles (what to us are low dose cycles, anyways), and then he posted a few more with higher doses (like the test/tren/anadrol cycle) where he advocates something like 500 mg/week test, 100 mg anadrol/day, and 150 mg/week of tren. That seems like the most he's willing to advocate. I would like to see actual data on dose-responses from subjects in studies that looked at doses WE COMMONLY take. That would be far more informative. Except, this will probably never happen, as research on aas -- in a clinically supervised, medical setting -- is discouraged and/or never brought up. Just think... if they were able to do these kinds of studies, then wouldn't people be better off in the long run? Wouldn't you have fewer people taking excessive amounts of aas and getting adverse health effects? Too bad. cest la vie